Emerging molecular markers of cancer (original) (raw)
Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell61, 759–767 (1990). CASPubMed Google Scholar
Feneley, M. R. & Partin, A. W. Diagnosis of localized prostate cancer: 10 years of progress. Curr. Opin. Urol.10, 319–327 (2000). CASPubMed Google Scholar
Benson, A. B., et al. NCCN practice guidelines for colorectal cancer. Oncology14, 203–212 (2000). PubMed Google Scholar
Olsen, O. & Gotzsche, P. C. Cochrane review on screening for breast cancer with mammography. Lancet358, 1340–1342 (2001). CASPubMed Google Scholar
Pietras, R. J. et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene10, 2435–2446 (1995). CASPubMed Google Scholar
Harris, L. N. et al. Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy. J. Clin. Oncol.19, 1698–1706 (2001). CASPubMed Google Scholar
Yancopoulos, G. D., Klagsbrun, M. & Folkman, J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell93, 661–664 (1998). CASPubMed Google Scholar
Sawhney, R. S. et al. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. J. Biol. Chem.277, 75–86 (2002). CASPubMed Google Scholar
Gold, P. & Freedman, S. O. Tests for carcinoembryonic antigen. Role in diagnosis and management of cancer. JAMA234, 190–192 (1975). CASPubMed Google Scholar
Shapiro, B. et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer51, 2116–2120 (1983). CASPubMed Google Scholar
Leon, S. A. et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res.37, 646–650 (1977). CASPubMed Google Scholar
Anker, P., Lyautey, J., Lederrey, C. & Stroun, M. Circulating nucleic acids in plasma or serum. Clin. Chim. Acta313, 143–146 (2001).References10–12establish and discuss the significance of the presence of free DNA in the serum of patients with cancer. CASPubMed Google Scholar
Sidransky, D. et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science252, 706–709 (1991). CASPubMed Google Scholar
Sidransky, D. et al. Identification of RAS oncogene mutations in the stool of patients with curable colorectal tumors. Science256, 102–105 (1992).References13and14establish the ability to detect oncogene mutations in body fluids. CASPubMed Google Scholar
Mills, N. E. et al. Detection of KRAS oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl Cancer Inst.87, 1056–1060 (1995). CASPubMed Google Scholar
Tobi, M., Luo, F. C. & Ronai, Z. Detection of KRAS mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl Cancer Inst.86, 1007–1010 (1994). CASPubMed Google Scholar
Dong, S. M. et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J. Natl Cancer Inst.93, 858–865 (2001).References15–17use multiple genetic targets to identify cancer cells in stool DNA. CASPubMed Google Scholar
Ahlquist, D. A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology119, 1219–1227 (2000). CASPubMed Google Scholar
Traverso, G. et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med.346, 311–320 (2002). CASPubMed Google Scholar
Jackson, P. E. et al. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res.61, 33–35 (2001). CASPubMed Google Scholar
Sun, X., Hung, K., Wu, L., Sidransky, D. & Guo, B. Detection of tumor mutations in the presence of excess amounts of normal DNA. Nature Biotechnol.20, 186–189 (2002). CAS Google Scholar
Brennan, J. A. et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med.332, 429–435 (1995). CASPubMed Google Scholar
Hayashi, N. et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res.54, 3853–3856 (1994).References22and23establish the use of oncogene mutations in the staging of cancer. CASPubMed Google Scholar
Mao, L. et al. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A91, 9871–9875 (1994). CASPubMedPubMed Central Google Scholar
Mao, L. et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science271, 659–662 (1996). CASPubMed Google Scholar
Steiner, G., Schoenberg, M. P., Linn, J. F., Mao, L. & Sidransky, D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Med.3, 621–624 (1997). CASPubMed Google Scholar
Spafford, M. F. et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin. Cancer Res.7, 607–612 (2001). CASPubMed Google Scholar
Nawroz, H. et al. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med.2, 1035–1037 (1996).References25–28highlight the use of microsatellite analysis in cancer detection. CASPubMed Google Scholar
Chen, X. Q. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nature Med.2, 1033–1035 (1996). CASPubMed Google Scholar
Ahrendt, S. A. et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Natl Cancer Inst.91, 332–339 (1999). CASPubMed Google Scholar
Medintz, I. L. et al. Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res.10, 1211–1218 (2000). CASPubMedPubMed Central Google Scholar
Hacia, J. G. et al. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nature Genet.22, 164–167 (1999). CASPubMed Google Scholar
Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet.16, 168–174 (2000). CASPubMed Google Scholar
Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med.1, 686–692 (1995). CASPubMed Google Scholar
Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. & Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA93, 9821–9826 (1996).A method for detecting methylated markers by PCR. CASPubMedPubMed Central Google Scholar
Rosas, S. L. et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res.61, 939–942 (2001). CASPubMed Google Scholar
Belinsky, S. A. et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl Acad. Sci. USA95, 11891–11896 (1998). CASPubMedPubMed Central Google Scholar
Palmisano, W. A. et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res.60, 5954–5958 (2000). CASPubMed Google Scholar
Esteller, M. et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res.59, 67–70 (1999). CASPubMed Google Scholar
Sanchez-Cespedes, M. et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res.60, 892–895 (2000). CASPubMed Google Scholar
Grady, W. M., Rajput, A., Lutterbaugh, J. D. & Markowitz, S. D. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res.61, 900–902 (2001). CASPubMed Google Scholar
Kawakami, K. et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl Cancer Inst.92, 1805–1811 (2000). CASPubMed Google Scholar
Usadel, H. et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res.62, 371–375 (2002).References42and43highlight the use of quantitative methylation in cancer detection. CASPubMed Google Scholar
Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res.61, 3225–3229 (2001).A comprehensive list of methylated genes in human cancer. CASPubMed Google Scholar
Jeronimo, C. et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J. Natl Cancer Inst.93, 1747–1752 (2001). CASPubMed Google Scholar
Warburg, O., Geissler, A. W. & Lorenz, S. [On growth of cancer cells in media in which glucose is replaced by galactose]. Hoppe Seylers Z. Physiol. Chem.348, 1686–1687 (1967). CASPubMed Google Scholar
Polyak, K. et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genet.20, 291–293 (1998). CASPubMed Google Scholar
Fliss, M. S. et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science287, 2017–2019 (2000). CASPubMed Google Scholar
Sanchez-Cespedes, M. et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res.61, 7015–7019 (2001).References47–49address the identification of mitochondrial DNA mutations in tumours and clinical samples. CASPubMed Google Scholar
Sherman, M. E. et al. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer81, 89–97 (1997). CASPubMed Google Scholar
Capone, R. B. et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin. Cancer Res.6, 4171–4175 (2000). CASPubMed Google Scholar
Lo, Y. M. et al. Quantitative and temporal correlation between circulating cell-free Epstein–Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res.59, 5452–5455 (1999). CASPubMed Google Scholar
Lo, Y. M. et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein–Barr virus DNA. Cancer Res.60, 6878–6881 (2000). CASPubMed Google Scholar
Datta, Y. H. et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol.12, 475–482 (1994). CASPubMed Google Scholar
Gerhard, M. et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol.12, 725–729 (1994). CASPubMed Google Scholar
Krismann, M. et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol.13, 2769–2775 (1995). CASPubMed Google Scholar
Katz, A. E. et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer75, 1642–1648 (1995). CASPubMed Google Scholar
Smith, B. et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet338, 1227–1229 (1991). CASPubMed Google Scholar
Foss, A. J. et al. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br. J. Cancer72, 155–159 (1995). CASPubMedPubMed Central Google Scholar
Brossart, P. et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res.55, 4065–4068 (1995). CASPubMed Google Scholar
Zippelius, A. et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J. Clin. Oncol.15, 2701–2708 (1997). CASPubMed Google Scholar
Taback, B. et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical state of disease. Cancer Res.61, 8845–8850 (2001).References55–62highlight the clinical issues that surround reverse transcriptase PCR detection of cancer cells. CASPubMed Google Scholar
Chu, E. et al. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Mol. Pharmacol.39, 136–143 (1991). CASPubMed Google Scholar
Salonga, D. et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin. Cancer Res.6, 1322–1327 (2000). CASPubMed Google Scholar
Ohara, K. et al. Utility of serum CA19-9 monitoring in preoperative radiotherapy for pancreatic cancer. Hepatogastroenterology48, 859–863 (2001). CASPubMed Google Scholar
Slesak, B. et al. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA19-9. Cancer89, 83–88 (2001). Google Scholar
Urgell, E. et al. Prospective evaluation of the contribution of KRAS mutational analysis and CA19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer. Eur. J. Cancer36, 2069–2075 (2000). CASPubMed Google Scholar
Canizares, F. et al. Preoperative values of CA15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis. Tumour Biol.22, 273–281 (2001). CASPubMed Google Scholar
Sjostrom, J. et al. Serum tumour markers CA15-3, TPA, hCGβ and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand. J. Clin. Lab. Invest.61, 431–441 (2001). CASPubMed Google Scholar
Liefers, G. J. et al. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med.339, 223–228 (1998). CASPubMed Google Scholar
Rosell, R., Green, M. & Gumerlock, P. Advances in the treatment of non-small cell lung cancer: molecular markers take the stage. Semin. Oncol.28, 28–34 (2001). CASPubMed Google Scholar
Wright, W. E., Shay, J. W. & Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res.23, 3794–3795 (1995).This study decribes the TRAP protocol for measuring telomerase activity. CASPubMedPubMed Central Google Scholar
Nakamura, T. M. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science277, 955–959 (1997). CASPubMed Google Scholar
Califano, J. et al. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res.56, 5720–5722 (1996). CASPubMed Google Scholar
Yoshida, K. et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer75, 548–553 (1997). CASPubMedPubMed Central Google Scholar
Yoshida, K. et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer79, 362–369 (1997). CASPubMed Google Scholar
Jassem, E. et al. Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance. Lung Cancer31, 17–23 (2001). CASPubMed Google Scholar
Yamaguchi, K. et al. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients. Int. J. Cancer89, 524–528 (2000). CASPubMed Google Scholar
Lubin, R. et al. Serum p53 antibodies as early markers of lung cancer. Nature Med.1, 701–702 (1995). CASPubMed Google Scholar
Schena, M. et al. Parallel human genome analysis: microarray-based expression monitoring of 1,000 genes. Proc. Natl Acad. Sci. USA93, 10614–10619 (1996). CASPubMedPubMed Central Google Scholar
Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet.23, 41–46 (1999). CASPubMed Google Scholar
Velculescu, V. E., Zhang, L., Vogelstein B. & Kinzler, K. W. Serial analysis of gene expression. Science270, 368–371 (1995). Google Scholar
Argani, P. et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res7, 3862–3868 (2001). CASPubMed Google Scholar
Ahrendt, S. A. et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc. Natl Acad. Sci. USA96, 7382–7387 (1999). CASPubMedPubMed Central Google Scholar
Hanash, S. 2-D or not 2-D: is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting. Proteomics1, 635–637 (2001). CASPubMed Google Scholar
Paweletz, C. P., Liotta, L. A. & Petricoin, E. F. New technologies for biomarker analysis of prostate cancer progression: laser capture microdissection and tissue proteomics. Urology57, 160–163 (2001). CASPubMed Google Scholar
Bichsel, V. E., Liotta, L. A. & Petricoin, E. F. Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J.7, 69–78 (2001). CASPubMed Google Scholar
Wall, D. B. et al. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal. Chem.72, 1099–1111 (2000). CASPubMed Google Scholar
Verma, M., Wright, G. L. Jr, Hanash, S. M., Gopal-Srivastava, R. & Srivastava, S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann. NY Acad. Sci.945, 103–115 (2001). CASPubMed Google Scholar
Madoz-Gurpide, J. et al. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics1, 1279–1287 (2001). CASPubMed Google Scholar
Petricoin, E. F. et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).The use of proteomics to detect protein patterns in the serum of patients with ovarian cancer. CASPubMed Google Scholar
Le Naour, F. et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res.7, 3328–3335 (2001). CASPubMed Google Scholar
Brichory, F., Beer, D., LeNaour, F., Giordano, T. & Hanash, S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res.61, 7908–7912 (2001). CASPubMed Google Scholar
Srinivas, P. R., Srivastava, S., Hanash, S. & Wright, G. L. Jr. Proteomics in early detection of cancer. Clin. Chem.47, 1901–1911 (2001). CASPubMed Google Scholar
Rawlings, C. J. & Searls, D. B. Computational gene discovery and human disease. Curr. Opin. Genet. Dev.7, 416–423 (1997). CASPubMed Google Scholar